TATE & LYLE

For the year ended 31 March 2026, Tate & Lyle reported reported revenue up 16% to £16bn thanks to the acquisition of CP Kelco, while pro‑forma revenue on a like‑for‑like basis fell 3%. Adjusted EBITDA was £415m (currency‑adjusted -3%), adjusted pre‑tax profit £238m (-5%) and adjusted earnings per share £0.404; the full‑year dividend remains unchanged at £0.198. The share price rose slightly by 0.67% after the announcement. Management highlights integration successes but continues to see geopolitical risks, weak demand in core markets and maintains a cautious outlook. » More on de.investing.com

Nick Hampton, CEO of Tate & Lyle for eight years, is reportedly preparing to resign, according to industry sources. The company is said to be working with executive search consultants on finding a successor; a departure could take place later this year. Since Hampton took office the stock has fallen about 34 percent, it dropped 42.3 percent in 2025, and the company had guided to a slight decline in revenue and core profit for the fiscal year. Tate & Lyle is, among other things, a supplier of ingredients for the sweetener Splenda. » More on de.investing.com

Tate & Lyle reported Q3 trading in line with expectations and reiterated unchanged full-year guidance, with pro forma constant-currency revenue down about 2% and reported group revenue up ~15% after including CP Kelco. Management prioritizes returning to top-line growth via renewed customer framework agreements, selective pricing investments, and higher customer engagement (cross-selling pipeline +33%), while innovation pipeline grows double digits. Integration of CP Kelco and a five-year $200m productivity programme are expected to offset pricing investments and a ~2–3% FX revenue headwind, with run-rate cost synergies targeted to exceed $50m by end-FY27. The company highlighted demand themes such as fiber fortification, renovation for value, and sugar-reduction mouthfeel solutions as drivers of future growth. » More on finance.yahoo.com